Article
Diacylglycerol kinase η modulates oncogenic properties of lung cancer cells.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Jan 2014
Nakano T, Iravani A, Kim M, Hozumi Y, Lohse M, Reichert E, Crotty T M, Stafforini D M, Topham M K
Abstract excerpt
PURPOSE: Lung cancer is a leading cause of cancer deaths and efforts are underway to identify novel therapies to treat these tumors. Diacylglycerol kinase η (DGKη), an enzyme that phosphorylates diacylglycerol to form phosphatidic acid, has been shown to modulate MAPK signaling downstream of EGFR, which is an oncogenic driver in some lung cancers. Since mutations in EGFR and K-Ras are common in lung cancer, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.